Literature DB >> 14704219

Estrogen replacement increases spinophilin-immunoreactive spine number in the prefrontal cortex of female rhesus monkeys.

Yong Tang1, William G M Janssen, Jiandong Hao, Jeffrey A Roberts, Heather McKay, Bill Lasley, Patrick B Allen, Paul Greengard, Peter R Rapp, Jeffrey H Kordower, Patrick R Hof, John H Morrison.   

Abstract

While studies have shown that estrogen affects hippocampal spine density and function, behavioral studies in humans and nonhuman primates have also implicated the prefrontal cortex in the effects of estrogen on cognition. However, the potential for similar estrogen-induced increases in spines and synapses in the prefrontal cortex has not been investigated in primates. Moreover, it is not known if such an estrogen effect would be manifested throughout the neocortex or primarily in the regions involved in cognition. Therefore, we investigated the effects of estrogen on dendritic spines in the prefrontal and primary visual cortices of young rhesus monkeys. Young female monkeys were ovariectomized and administered either estradiol cypionate or vehicle by intramuscular injection. Using an antibody against the spine-associated protein, spinophilin, spine numbers were estimated in layer I of area 46 and in layer I of the opercular portion of area V1 (V1o). Spine numbers in layer I of area 46 were significantly increased (55%) in the ovariectomy + estrogen group compared to the ovariectomy + vehicle group, yet spine numbers in layer I of area V1o were equivalent across the two groups. The present results suggest that estrogen's effects on synaptic organization influence select neocortical layers and regions in a primate model, and provide a morphological basis for enhanced prefrontal cortical functions following estrogen replacement.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14704219     DOI: 10.1093/cercor/bhg121

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  78 in total

1.  Orbitofrontal cortex activity related to emotional processing changes across the menstrual cycle.

Authors:  Xenia Protopopescu; Hong Pan; Margaret Altemus; Oliver Tuescher; Margaret Polanecsky; Bruce McEwen; David Silbersweig; Emily Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-24       Impact factor: 11.205

Review 2.  Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women.

Authors:  John H Morrison; Roberta D Brinton; Peter J Schmidt; Andrea C Gore
Journal:  J Neurosci       Date:  2006-10-11       Impact factor: 6.167

3.  Effects of androgens and estradiol on spine synapse formation in the prefrontal cortex of normal and testicular feminization mutant male rats.

Authors:  Tibor Hajszan; Neil J MacLusky; Jamie A Johansen; Cynthia L Jordan; Csaba Leranth
Journal:  Endocrinology       Date:  2007-02-22       Impact factor: 4.736

Review 4.  Can endocrine disruptors influence neuroplasticity in the aging brain?

Authors:  Bernard Weiss
Journal:  Neurotoxicology       Date:  2007-02-04       Impact factor: 4.294

Review 5.  Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression.

Authors:  P Licznerski; R S Duman
Journal:  Neuroscience       Date:  2012-10-02       Impact factor: 3.590

6.  Selective estrogen receptor modulators (SERMs) enhance neurogenesis and spine density following focal cerebral ischemia.

Authors:  Mohammad M Khan; Chandramohan Wakade; Liesl de Sevilla; Darrell W Brann
Journal:  J Steroid Biochem Mol Biol       Date:  2014-05-09       Impact factor: 4.292

7.  Knockout of spinophilin, an endogenous antagonist of arrestin-dependent alpha2-adrenoceptor functions, enhances receptor-mediated antinociception yet does not eliminate sex-related differences.

Authors:  Subodh Nag; Qin Wang; Lee E Limbird; Sukhbir S Mokha
Journal:  Behav Brain Res       Date:  2008-10-08       Impact factor: 3.332

Review 8.  Estrogen therapy and cognition: a review of the cholinergic hypothesis.

Authors:  Robert B Gibbs
Journal:  Endocr Rev       Date:  2009-12-17       Impact factor: 19.871

9.  Potential role of estrogen in the pathobiology and prevention of Alzheimer's disease.

Authors:  Whitney Wharton; Carey E Gleason; Katelin R Lorenze; Tamara S Markgraf; Michele L Ries; Cynthia M Carlsson; Sanjay Asthana
Journal:  Am J Transl Res       Date:  2009-01-20       Impact factor: 4.060

10.  Estrogen replacement therapy, Alzheimer's disease, and mild cognitive impairment.

Authors:  Ruth A Mulnard; Marìa M Corrada; Claudia H Kawas
Journal:  Curr Neurol Neurosci Rep       Date:  2004-09       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.